• FCMS
  • Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust
  • Rotherham Doncaster and South Humber NHS Foundation Trust
  • Nottingham and Nottinghamshire
  • South Yorkshire ICB

For information and guidance regarding referral to Female Continence Clinic for Overactive Bladder on the SY MO website click here

For information and guidance regarding Nocturnal Enuresis/Bedwetting in children the SY MO website Click Here ( to be added ) 

Hide Non-Formulary Medicines and Products

Urinary Incontinence

 

Pack Price
30 tablet £1.17
Pack Price
30 tablet £0.94

Overactive bladder syndrome

Mirabegron should not be prescribed for patients age 17years and under.

See Guideline (pathway) for referral to Secondary Care Female Continence Clinic for Overactive Bladder 

NICE TA 290
Mirabegron is recommended as an option for treating the symptoms of overactive
bladder only for people in whom antimuscarinic drugs are contraindicated or clinically ineffective, or have unacceptable side effects. People currently receiving mirabegron that is not recommended for them in should be able to continue treatment until they and their clinician consider it appropriate to stop.

Pack Price
30 tablet £29.00
Pack Price
30 tablet £29.00

Stress Urinary incontinence

NG123 Urinary incontinence and pelvic organ prolapse in women: management

Pack Price
28 capsule £2.73
Pack Price
56 capsule £2.75

Nocturnal Enuresis/Bedwetting in children

Follow Local guidance 

Pack Price
30 tablet (3 x 10 tablets) £30.34

Overactive bladder syndrome

NICE NG123

Symptomatic treatment of adults with overactive bladder syndrome

Pack Price
30 tablet £26.68

Managing neurogenic detrusor overactivity in people 6 years and over with spinal cord injury or spina bifida (terminated appraisal)

Rationale 7

Brand - Vesoxx

NICE TA 1154

Pack Price
1 vial
10 vial

Urinary frequency, Urinary urgency, Incontinence

Refer to Place based formularies/guidelines

Moderate to severe urinary frequency, urgency, and obstructive symptoms associated with benign prostatic hyperplasia when monotherapy ineffective

Rationale 4

For cost-effective prescribing it is recommended that Tamsulosin and Solifenacin are prescribed separately